Admetsys has created an artificial intelligence (AI) solution to monitor critically ill diabetes patients. It's a tiny chip that can monitor blood sugar levels in real time and trigger software to administer insulin or glucose via a drip that a patient is hooked up to. The company's solution doesn't require human intervention.
